The human body makes use of several control mechanisms to prevent cancer. Raiborg's thesis work reveals detailed molecular insight into one of these processes, receptor downregulation. After a growth factor receptor has received a growth stimulatory signal, the activated receptor and its ligand are taken up into cells by endocytosis and transported via endosomes to lysosomes for degradation. The activated growth factor receptors that are destined for degradation are labeled with a molecular tag, ubiquitin. By degrading the receptor and its growth factor, the cell can assure that the receptor is silenced. This is important to prevent uncontrolled signaling. In contrast to activated growth factor receptors, endocytosed nutrient receptors are recycled back to the cell surface for reuse. The fate of the receptors is settled at the level of early endosomes, which act as the main sorting stations in the endocytic pathway. A long-standing question in this field has been how the cell is able to sort the receptors in different directions from the endosome.
project several components were shown to cooperate with Hrs in the sorting process: clathrin, STAM, Eps15, AIP4, etc. The work is well planned, and the methods used are excellent and always up to date and adapted to the problems investigated. The results presented in the five articles give novel, solid, and detailed information about molecular mechanisms involved in sorting and targeting of endocytosed proteins. The dissertation is a major contribution to novel insight into receptor downregulation.
